Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas

Besma Bel Hadj Jrad, Amel Chatti, Adnene Laatiri, Slim Ben Ahmed, Abdelaziz Romdhane, Salem Ajimi, Lotfi Chouchane

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The tumor necrosis factor (TNF) is a pro-inflammatory cytokine involved in the severity of different immune-regulated diseases including autoimmune, infectious, and malignant diseases. Chronic immune system stimulation could be a potential etiologic factor in these diseases. Given the determining role of TNF acting early in the immune response, we investigated the effect of an inherited genetic polymorphism at TNF promoter (-308A/G) on a predisposition to non-Hodgkin's lymphoma (NHL). The genotype distribution was determined in 194 patients with NHL and 160 age- and sex-matched population-based controls. The comparison of the -308TNF genotypes between the NHL patients and the controls showed a significant excess of A/A genotype that is previously associated with higher TNF production. Indeed, the A/A genotype is present in 7.7% of the cases, but in only 2.5% of the controls. This genotype is associated with a significant increased risk of NHL (odds ratio = 3.63, P = 0.028). These results indicate that the genetic polymorphism which could lead to an increased TNF production or a neighboring gene within the MHC region may influence the susceptibility to NHL in Tunisian population. Other epidemiologic studies carried out in both the Tunisian population and elsewhere are needed to confirm this finding.

Original languageEnglish
Pages (from-to)117-122
Number of pages6
JournalEuropean Journal of Haematology
Volume78
Issue number2
DOIs
Publication statusPublished - Feb 2007
Externally publishedYes

Fingerprint

Non-Hodgkin's Lymphoma
Tumor Necrosis Factor-alpha
Genotype
Genes
Genetic Polymorphisms
Population Control
Immune System Diseases
Population
Communicable Diseases
Epidemiologic Studies
Immune System
Odds Ratio
Cytokines

Keywords

  • Genetic polymorphism
  • Non-Hodgkin's lymphoma
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Hematology

Cite this

Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. / Bel Hadj Jrad, Besma; Chatti, Amel; Laatiri, Adnene; Ahmed, Slim Ben; Romdhane, Abdelaziz; Ajimi, Salem; Chouchane, Lotfi.

In: European Journal of Haematology, Vol. 78, No. 2, 02.2007, p. 117-122.

Research output: Contribution to journalArticle

Bel Hadj Jrad, Besma ; Chatti, Amel ; Laatiri, Adnene ; Ahmed, Slim Ben ; Romdhane, Abdelaziz ; Ajimi, Salem ; Chouchane, Lotfi. / Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas. In: European Journal of Haematology. 2007 ; Vol. 78, No. 2. pp. 117-122.
@article{affbdb60d4c0472494dde67377e5d6ca,
title = "Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas",
abstract = "The tumor necrosis factor (TNF) is a pro-inflammatory cytokine involved in the severity of different immune-regulated diseases including autoimmune, infectious, and malignant diseases. Chronic immune system stimulation could be a potential etiologic factor in these diseases. Given the determining role of TNF acting early in the immune response, we investigated the effect of an inherited genetic polymorphism at TNF promoter (-308A/G) on a predisposition to non-Hodgkin's lymphoma (NHL). The genotype distribution was determined in 194 patients with NHL and 160 age- and sex-matched population-based controls. The comparison of the -308TNF genotypes between the NHL patients and the controls showed a significant excess of A/A genotype that is previously associated with higher TNF production. Indeed, the A/A genotype is present in 7.7{\%} of the cases, but in only 2.5{\%} of the controls. This genotype is associated with a significant increased risk of NHL (odds ratio = 3.63, P = 0.028). These results indicate that the genetic polymorphism which could lead to an increased TNF production or a neighboring gene within the MHC region may influence the susceptibility to NHL in Tunisian population. Other epidemiologic studies carried out in both the Tunisian population and elsewhere are needed to confirm this finding.",
keywords = "Genetic polymorphism, Non-Hodgkin's lymphoma, Tumor necrosis factor",
author = "{Bel Hadj Jrad}, Besma and Amel Chatti and Adnene Laatiri and Ahmed, {Slim Ben} and Abdelaziz Romdhane and Salem Ajimi and Lotfi Chouchane",
year = "2007",
month = "2",
doi = "10.1111/j.1600-0609.2006.00784.x",
language = "English",
volume = "78",
pages = "117--122",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas

AU - Bel Hadj Jrad, Besma

AU - Chatti, Amel

AU - Laatiri, Adnene

AU - Ahmed, Slim Ben

AU - Romdhane, Abdelaziz

AU - Ajimi, Salem

AU - Chouchane, Lotfi

PY - 2007/2

Y1 - 2007/2

N2 - The tumor necrosis factor (TNF) is a pro-inflammatory cytokine involved in the severity of different immune-regulated diseases including autoimmune, infectious, and malignant diseases. Chronic immune system stimulation could be a potential etiologic factor in these diseases. Given the determining role of TNF acting early in the immune response, we investigated the effect of an inherited genetic polymorphism at TNF promoter (-308A/G) on a predisposition to non-Hodgkin's lymphoma (NHL). The genotype distribution was determined in 194 patients with NHL and 160 age- and sex-matched population-based controls. The comparison of the -308TNF genotypes between the NHL patients and the controls showed a significant excess of A/A genotype that is previously associated with higher TNF production. Indeed, the A/A genotype is present in 7.7% of the cases, but in only 2.5% of the controls. This genotype is associated with a significant increased risk of NHL (odds ratio = 3.63, P = 0.028). These results indicate that the genetic polymorphism which could lead to an increased TNF production or a neighboring gene within the MHC region may influence the susceptibility to NHL in Tunisian population. Other epidemiologic studies carried out in both the Tunisian population and elsewhere are needed to confirm this finding.

AB - The tumor necrosis factor (TNF) is a pro-inflammatory cytokine involved in the severity of different immune-regulated diseases including autoimmune, infectious, and malignant diseases. Chronic immune system stimulation could be a potential etiologic factor in these diseases. Given the determining role of TNF acting early in the immune response, we investigated the effect of an inherited genetic polymorphism at TNF promoter (-308A/G) on a predisposition to non-Hodgkin's lymphoma (NHL). The genotype distribution was determined in 194 patients with NHL and 160 age- and sex-matched population-based controls. The comparison of the -308TNF genotypes between the NHL patients and the controls showed a significant excess of A/A genotype that is previously associated with higher TNF production. Indeed, the A/A genotype is present in 7.7% of the cases, but in only 2.5% of the controls. This genotype is associated with a significant increased risk of NHL (odds ratio = 3.63, P = 0.028). These results indicate that the genetic polymorphism which could lead to an increased TNF production or a neighboring gene within the MHC region may influence the susceptibility to NHL in Tunisian population. Other epidemiologic studies carried out in both the Tunisian population and elsewhere are needed to confirm this finding.

KW - Genetic polymorphism

KW - Non-Hodgkin's lymphoma

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=33846085697&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846085697&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0609.2006.00784.x

DO - 10.1111/j.1600-0609.2006.00784.x

M3 - Article

VL - 78

SP - 117

EP - 122

JO - European Journal of Haematology

JF - European Journal of Haematology

SN - 0902-4441

IS - 2

ER -